Mangosteen extract shows potential as a future treatment for Schizophrenia

Mangosteen extract shows potential as a future treatment for Schizophrenia

The University of Queensland has begun clinical trials to evaluate whether extracts from Mangosteen fruit can help ease symptoms of psychosis. Previous studies have found the potent antioxidants extracted from Mangosteen rind to be a safe and effective treatment, with no side-effects.

These promising results have prompted Queensland Brain Institute Professor John McGrath to conduct a new trial evaluating Mangosteens effectiveness in people diagnosed with Schizophrenia and is excited by the prospect of a new, natural way to improve symptoms especially as no negative side-effects have been reported.

Professor McGrath stated that;

"This is a gentle and safe intervention which evidence so far suggests could improve symptoms, and it’s important we investigate its potential as a matter of urgency”

Mangosteen, a tropical evergreen fruit native to Indonesia, contains concentrated amounts of unique antioxidants called xanthones. It is these compounds which are being studied as potential therapy for reducing symptoms of Schizophrenia such as hallucinations, delusions, low mood and energy levels.

150 patients have been recruited for the study which will run for a total of 24 weeks. It is thought that these potent antioxidants may be able to restrict potentially damaging free radicals which can build up in certain disease states.

This research is exciting news for those affected by the disease and shows another promising health benefit of this amazing tropical fruit.

To learn more about Mangosteen and its health benefits click here.